Until recently, the use of the hormone replacement for postmenopausal women (replacement of estrogen deficiency and progesterone because they stopped after menopause by taking estrogen and progesterone after menopause) was thought to reduce the incidence of coronary disease. Recent studies have shown that the use of hormonal replacement to reduce the incidence Because coronary artery disease is not justified because it is accompanied by an increase in the risk of breast cancer and vaginal bleeding, the therapist may see that the patient may benefit from hormone replacement therapy if proven to have coronary disease and have no risk of breast cancer.